Efforts to reduce central line-associated bloodstream infections (CLABSIs) have resulted in decreased rates, however, these hospital-acquired conditions remain a challenge for pediatric hematology/oncology/BMT patients. Although pediatric hem/onc centers have undertaken multiple interventions to reduce CLABSIs, the evidence base to guide CLABSI reduction efforts in this population remains limited.
This session will examine and appraise current evidence related to risk factors for CLABSIs, causative organisms, and interventions targeted at reducing CLABSIs with attention to the pediatric hem/onc/BMT population. The session will address challenges inherent in measuring outcomes of interventions to reduce CLABSIs. Finally, the session will equip attendees in applying principles of practice-based evidence in proposing interventions to reduce CLABSIs.
- Opening Keynote: Secrets Everyone in Health Care Needs to Know (101)
- General Session: International Pediatric Hematology/Oncology Nursing Initiatives: Challenges and Opportunities (102)
- It's All GREEK To Me! The NEPENTHE Trial for Relapsed/Refractory Neuroblastoma; Personalized Molecularly Targeted Treatment (200)
- A Sustainable Community Engagement Program Model to Address Hematopoietic Cell Transplantation Education Needs for Patients with Sickle Cell Disease (201)
- Nursing Management for the Successful Application of the Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy (212)
- Lauri Linder, PhD APRN CPON®